Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Moodys
Merck
McKinsey
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tanezumab

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Tanezumab: Sponsors, patents, clinical trial progress

Tanezumab is an investigational drug.

There have been 16 clinical trials for Tanezumab. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2009.

The most common disease conditions in clinical trials are Osteoarthritis, Osteoarthritis, Knee, and Low Back Pain. The leading clinical trial sponsors are Pfizer, Eli Lilly and Company, and [disabled in preview].

Recent Clinical Trials for Tanezumab
TitleSponsorPhase
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical StudiesEli Lilly and CompanyPhase 3
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical StudiesPfizerPhase 3
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder ReplacementEli Lilly and CompanyPhase 3

See all Tanezumab clinical trials

Clinical Trial Summary for Tanezumab

Top disease conditions for Tanezumab
Top clinical trial sponsors for Tanezumab

See all Tanezumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKesson
Merck
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.